BenevolentAI Cuts Workforce, Pipeline in Strategic Realignment

Following a strategic review, British AI drug discovery company BenevolentAI announced a reorganization initiative Thursday aimed at optimizing its pipeline and technology platforms to reduce its expenditures and maximize value for stakeholders.